PRINCE WILLIAM COUNTY, VA-Three years after announcing its decision to build a new insulin manufacturing plant at the 1,600-acre Innovation@Prince William business park, Eli Lilly and Co. has revealed an alteration to the blueprint. The Indianapolis-headquartered pharmaceutical giant will reduce the size of the planned facility–which will produce the diabetes drugs Humulin and Humalog–from the originally stipulated 600,000 sf to 300,000 sf.

The development cost will go from a projected $425 million when the plan was announced in 2002 to $325 million. An Eli Lilly official announced the news in a recent meeting of the Prince William Board of County Supervisors.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.